Cardiac Science Powerheart Approval Revitalizes Stock In November
This article was originally published in The Gray Sheet
Executive Summary
The possibility of the next-generation Powerheart bedside monitor-defibrillator emerging as a standard fixture in the acute-care setting helped to almost double Cardiac Science's stock price for November
You may also be interested in...
Cardiac Science
Irvine, California-based firm commences shipping second-generation Powerheart Cardiac Rhythm Module, announced April 2. Cleared in November 2001, the device is roughly one-quarter the size and one-third the cost of the original Powerheart (1"The Gray Sheet" Dec. 10, 2001, p. 21)...
Cardiac Science
Irvine, California-based firm commences shipping second-generation Powerheart Cardiac Rhythm Module, announced April 2. Cleared in November 2001, the device is roughly one-quarter the size and one-third the cost of the original Powerheart (1"The Gray Sheet" Dec. 10, 2001, p. 21)...
Cardiac Science Powerheart
Next-generation automated external defibrillator (AED) for public access commences worldwide shipping, following 510(k) clearance announced Feb. 5. Device incorporates the firm's RHYTHMx technology used in the Powerheart CRM hospital bedside version (1"The Gray Sheet" Dec. 10, 2001, p. 21). Marketing is being conducted by a 36-person direct AED U.S. sales force and distributors in over 40 countries. Addressing an AED market expected to reach $650 mil. by 2006, the device continuously monitors a victim's heart rhythm after revival and eliminates the need for the rescuer to determine if the victim has a pulse prior to attaching the device...